PKH26 probe in the study of the proliferation of chemoresistant leukemic sublines

Anticancer Research

Volumn 18, Issue 6 A, 1998, Pages 4243-4251

  Boutonnat, J ^a   Muirhead, K A ^b   Barbier, M ^a   Mousseau, M ^c   Ronot, X ^a   Seigneurin, D ^a  

^a INSTITUT ALBERT BONNIOT   (France)

^b SciGro Inc   (United States)

^c HÔPITAL MICHALLON   (France)

Author keywords

Chemoresistance; Flow cytometry; Hematological malignancies; Proliferation

Indexed keywords

FLUORESCENT DYE; GLYCOPROTEIN; MULTIDRUG RESISTANCE PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CELL CULTURE; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DYE DILUTION CURVE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY;

CELL DIVISION; CELL MEMBRANE; CELLS, CULTURED; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; FLUORESCENT DYES; HL-60 CELLS; HUMANS; K562 CELLS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; ORGANIC CHEMICALS; P-GLYCOPROTEIN;

EID: 0032421878     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. List AF: Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia 10: 937-942, 1996.
2. Raza A, Maheshwari Y, Yasin Z, Mandava N, Mayers G: A new method for studying cell cycle characteristics in ANLL using double-labelling with BrdUrd and 3H Tdr. Leuk Res 11: 1079-1084, 1987.
3. Horan P, Slezak S: Stable cell membrane labelling. Nature 340: 167-168, 1989.
4. Slezak S, Horan PK: Fluorescent in vivo tracking of hematopoietic cells. Blood 6: 2172-2177, 1989.
5. Bernstein JJ, Goldberg WJ, Law Jr: Migration of fresh human malignant astrocytoma cells into hydrated gel waters in vitro. J Neuro Onco 18: 151-161, 1993.
6. Wallace P, Palmer L, Perry-Lalley D, et al: Mechanisms of adoptive immunotherapy: improved methods for in vivo tracking of tumor-inilltrating lymphocytes and lymphokine- activated killer cells. Cancer Res 53: 2358-2367, 1993.
7. 125I-pkh95: characterization and efficacy as labels for in vitro and in vivo endothelial cell localization and tracking. J Surg Res 62: 23-28, 1996.
8. Hugo P, Kappler J, Godfrey D, Marrack P: A cell line that can induce thymocyte positive selection. Nature 360: 679-682, 1992.
9. Melnicoff MJ, Horan PK, Morahan PS: Kinetics of changes in peritoneal cell populations following acute inflammation. Cell Immunol 118: 178-191, 1989.
10. Poon RY, Ohlsson-Wilhem BM, Bagwell B, Muirhead KA: Use of PKH membrane intercalating dyes to monitor cell trafficking and function. Chapter 8 In: In Iiving color: Flow cytometry and cell sorting protocols (Eds. Rochelle A. Diamond and Sue Demaggio) In press.
11. Teare G, Horan P, Slezak S, Smith C, Hay J: Long-term tracking of lymphocytes in vivo: the migration of PKH-Labeled lymphocytes. Cell Immunol 134: 157-170, 1991.
12. Ashley D, Bol S, Waugh C, Kannourakis G: A novel approach to the measurement of different in vitro leukaemic cell growth parameters: the use of PKH GL fluorescent probes. Leuk Res 17: 873-882, 1993.
13. Boyd F: Identification of growth inhibited cells by retention of a lipophilic fluorescent dye. Cell Growth Differ 4: 777-784, 1993.
14. Yamamura Y, Rodriguez N, Schwartz A, Eylar E, Bagwell B, Yano N: A new flow cytometric method for quantitative assessment of lymphocyte mitogenic potentials. Cell Mol Bio 4: S121-S132, 1995.
15. Young J, Varma A, DiGuisto D, Backer M: Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture. Blood 2: 545-556, 1996.
16. Marie JP, Zhou DC, Gurbuxani S, Legrand O, Zittoun R: MDR1/P-glycoprotein in haematological neoplasms. Eur J Cancer 32: 1034-1038, 1996.
17. Legrand O, Perrot JY, Tang RP, et al: Expression of the multidrug resistance-associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells. B J Haematol 94: 23-33, 1996.
18. Denis-Gay M, Petit JM, Ratinaud MH: Rhodamine 123: Is it an appropriate dye to study P- glycoprotein activity in Adriamycin-resistant K562 cells? Anticancer Res 15: 121-126, 1995.
19. Loe DW, Deeley RG, Cole SPC: Biology of the multidrug resistance-associated protein, MRP. Eur J Cancer 32: 945-957, 1996.